Bend Bioscience Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2021

Location

Bend OR US

Primary Industry

Biotechnology

About

Founded in 2021 and based in Oregon, US, Bend Bioscience is an early-phase contract development and manufacturing organization (CDMO) that provides drug delivery R and D, drug development, and manufacturing services. It has approximately 20k square feet of laboratory, processing suites, warehouse, and office space. The founder, Dana Settell has 23 years of industry experience. The company is engaged in drug delivery R&D partnerships, product development, and early-phase manufacturing for enhanced formulations utilizing particle engineering-based drug delivery technologies. Its businesses can be categorized into bioavailability and spray-dried dispersions, particle engineering for inhaled therapeutics, solid dosage forms, stabilizing biotherapeutics, and drug delivery platform innovations.

Current Investors

NovaQuest Capital Management

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals

Website

www.bendbioscience.com

Company Stage

Growth Stage/Expansion

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.